British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-{alpha} treatments.
Ledingham
J
J
Wilkinson
C
C
Deighton
C
C
D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D009894:Opportunistic Infections / Q000139:chemically induced*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D014376:Tuberculosis / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D006113:United Kingdom
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha